Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001085037-09-000335
Filing Date
2009-06-19
Accepted
2009-06-19 13:15:12
Documents
1
Period of Report
2008-05-20

Document Format Files

Seq Description Document Type Size
1 form4durrant_ex.html 4  
1 form4durrant_ex.xml 4 9313
  Complete submission text file 0001085037-09-000335.txt   11172
Mailing Address 27 MARATHONOS AVE. 15351 ATHENS J3 00000
Business Address 27 MARATHONOS AVE. 15351 ATHENS J3 00000 30-210-603-4026
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 90, FAIRMOUNT ROAD WEST CALIFON NJ 07830-3330
Business Address
Durrant Cameron (Reporting) CIK: 0001421882 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51652 | Film No.: 09900721